9 employees
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
2019
$4.7M
from 4 investors over 4 rounds
Augustine Therapeutics raised $4.7M on December 16, 2019
Investors: KU Leuven Innovation & Entrepreneurship, VIB, AdBio partners and V-Bio Ventures